CD30+ lymphomatoid skin toxicity secondary to ipilimumab by Amelia E. Bush, BS, Andres Garcia, BS, Janet Li, MD, Jonathan Curry, MD, Susan Y. Chon, MD

Connect to this object online.

Durvalumab-associated generalized morphea with overlapping vitiligo by Julianna Martel, MD, Woo Cheal Cho, MD, John S. Runge, PhD, Anisha B. Patel, MD, Jean Tayar, MD, Karin Woodman, MD, Celyne Bueno Hume, MD, Jonathan Curry, MD, Meghan Heberton, MD

Connect to this object online.